All Bulletins

New Patent Issued in Japan (Patent No. 7802303) Posted on: January 19, 2026 Author: Ｃ４Ｕ株式会社

C4U Announces the License Agreement with Euglena for CRISPR-Cas3 Technology Posted on: January 16, 2026 Author: C4U Corporation

New Patent Issued in Europe (European Patent No. 4303310) Posted on: December 25, 2025 Author: C4U Corporation

C4U Announces the Second License Agreement with RACTHERA for CRISPR-Cas3 Technology Posted on: December 25, 2025 Author: C4U Corporation

Announcement of the 19th JIHS Global Infectious Diseases Forum Posted on: December 11, 2025 Author: Japan Institute of Health Security (JIHS)

Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others Posted on: December 8, 2025 Author: Global Health Innovative Technology Fund (GHIT Fund)

Luxna Deepens Collaboration with BioSpring to Advance Therapeutic Oligonucleotide Development Posted on: December 2, 2025 Author: Luxna Biotech Co., Ltd.

C4U and CiRA Entered Into a New Collaborative Research Agreement Posted on: December 2, 2025 Author: C4U Corporation

【Call for Startups】Investor Day Japan 2026 BioLabs Friends Present -Tell Us Your Biotech Story- Posted on: November 12, 2025 Author: 川崎市産業振興財団

New Patent Issued in the United State (Patent No. 12460271) Posted on: November 7, 2025 Author: C4U Corporation

Total Investment of Approx. USD 11.6 Million in TB and NTD R&D projects with Partners including FUJIFILM, Stop TB Partnership, and the Ohio State University Posted on: October 29, 2025 Author: 公益社団法人グローバルヘルス技術振興基金

C4U and Rebirthel Entered Into a Memorandum of Understanding Aiming for the Collaborative Research Posted on: October 28, 2025 Author: C4U Corporation